stars 1 stars 2 stars 3

Early diagnosis, better prognosis. We are Reccan, a young medtech company dedicated to improving the prognosis for patients diagnosed with pancreatic cancer. Our vision is to set a standard for early detection of pancreatic cancer and therefore save lives. We are working to change the trajectory of pancreatic cancer mortality by finding the cancer at an earlier stage than is possible today. Early detection makes interventions and treatments more effective.

Reccan Diagnostics Questions

The Reccan Diagnostics annual revenue was $1 million in 2026.

Anna Broden is the CEO of Reccan Diagnostics.

2 people are employed at Reccan Diagnostics.

Reccan Diagnostics is based in Lund, Skane.

The NAICS codes for Reccan Diagnostics are [32541, 325, 325413, 32, 3254].

The SIC codes for Reccan Diagnostics are [283, 28].

Top Reccan Diagnostics Employees

View Similar People
G2 Leader Summer 2026 G2 Best Est ROI Mid-Market Summer 2026 G2 Easiest Admin Mid-Market Summer 2026 G2 Most Implementable Summer 2026 G2 Best Results Mid-Market Summer 2026 G2 Lead Capture Mid-Market Summer 2026 Inc Fastest Growing Private Companies 2026 Inc Best Workplace 2026
g2crowd
G2Crowd Trusted
chromestore
300K+ Plugin Users